Expert consensus on the clinical application of Huang Kui Capsules in the treatment of chronic kidney disease
Chinese Association of Traditional Chinese Medicine Nephrology Branch
Expert Consensus Working Group on the Clinical Application of Huang Kui Capsules in Treating Chronic Kidney Disease
YANG Hong-tao
Abstract：The global prevalence of chronic kidney disease(CKD)has risen in recent years,which affects approximately 8.2％of the population in China.Traditional Chinese medicine plays a significant role in CKD treatment.Huang Kui Capsules are classified as a Category Ⅲ new traditional Chinese medicine,having the effects of clearing damp-heat,detoxifying,and reducing swelling,and have been widely used in the treatment of CKD since their introduction to the market.This consensus systematically sorts out the current clinical researches on Huang Kui Capsules,integrating practitioners'experiences in clinical application and adhering to the principles of"evidence-based medicine being primary,consensus being supplemental,and experience being a reference."Utilizing the Delphi method and nominal group technique,seven recommendations and suggestions have been developed,which outline the indications,target populations,dosage,combination therapy,precautions,adverse reactions,and preventions and management of adverse reactions of Huang Kui Capsules.The goal is to standardize the clinical drug use,reduce the risks,increase the efficacy,and improve patients'outcomes.This consensus serves as a reference for clinicians in traditional Chinese and Western medicine across various medical institutions in the rational use of Huang Kui Capsules.
Keywords：Huang Kui Capsuleschronic kidney diseaseexpert consensusclinical applicationChinese patent drug
Publication Date：2025-03-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：11( 216-226 )